arrow2 Comments
  1. [...] Nexavar (Sorafenib) – India: Controversial licence granted over patented cancer drug (IP Whiteboard) (IPKat) (Patent Law Practice Center) (Patent Docs) (Patent Baristas) (Patent Baristas) [...]

  2. [...] in IndiaFirst Coast NewsLives before profits: India issues first compulsory licenseSouth Asia MailPatent Baristasall 25 news [...]

Leave a Reply

You must be to post a comment.

Mobile Theme